검색어 : 통합검색[Andrade Levine.]
-
21
-
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease : A Multidisciplinary Delphi Study
-
Rahaghi, Franck F.;
Kolaitis, Nicholas A.;
Adegunsoye, Ayodeji;
de Andrade, Joao A.;
Flaherty, Kevin R.;
Lancaster, Lisa H.;
Lee, Joyce S.;
Levine, Deborah J.;
Preston, Ioana R.;
Safdar, Zeenat;
Saggar, Rajan;
Sahay, Sandeep;
Scholand, Mary Beth;
Shlobin, Oksana A.;
Zisman, David A.;
Nathan, Steven D.;
Advanced Lung Disease Clinic, Cleveland Clinic Florida, Weston, FL;
UCSF Pulmonary and Critical Care, San Francisco, CA;
Section of Pulmonary & Critical Care, The University of Chicago School of Medicine, Chicago, IL;
Vanderbilt Lung Institute, Vanderbilt University Medical Center, Nashville, TN;
Michigan Medicine Interstitial Lung Disease Program, University of Michigan, Ann Arbor, MI;
Vanderbilt University Medical Center, Nashville, TN;
Pulmonary Sciences & Critical Care, University of Colorado School of Medicine, Aurora, CO;
Pulmonary Hypertension Center, UT Health San Antonio, San Antonio, TX;
Pulmonary Hypertension Center, Tufts Medical Center, Boston, MA;
Houston Methodist, Houston, TX;
Pulmonary and Critical Care Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA;
Houston Methodist Lung Center, Houston, TX;
Pulmonary Medicine, University of Utah Health, Farmington, UT;
Inova Fairfax Heart & Lung Transplant Program, Inova Medical Group, Falls Church, VA;
(Chest : official publication of the American College of Chest Physicians,
v.162,
2022,
pp.145-155)
-
22
-
Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants
-
de Andrade, Kelvin C.;
Strande, Natasha T.;
Kim, Jung;
Haley, Jeremy S.;
Hatton, Jessica N.;
Frone, Megan N.;
Khincha, Payal P.;
Thone, Gretchen M.;
Mirshahi, Uyenlinh L.;
Schneider, Cynthia;
Desai, Heena;
Dove, James T.;
Smelser, Diane T.;
Levine, Arnold J.;
Maxwell, Kara N.;
Stewart, Douglas R.;
Carey, David J.;
Savage, Sharon A.;
;
(Hgg advances,
v.5,
2024,
pp.100242)
-
23
-
Clinical Outcomes After Valve Intervention in Rheumatic Mitral Valve Disease
-
da Silva Neves, Marco Auré
lio;
Fraga, Lucas Leal;
de Andrade, Moises Barbosa;
Nascimento, Bruno Ramos;
Gelape, Clá
udio Leo;
Brá
ulio, Renato;
Costa, Paulo Henrique Nogueira;
Teixeira, Marcia Fabrí
cia Almeida;
Melo, Paulo Henrique Moreira;
Athayde, Guilherme Rafael Sant’Anna;
Lodi-Junqueira, Lucas;
Levine, Robert A.;
Nunes, Maria Carmo Pereira;
;
(Global heart,
v.20,
2025,
pp.38)
-
24
-
Clinical outcomes and progression rate of tricuspid regurgitation in patients with rheumatic mitral valve disease
-
Caldas, Mô
nica M Costa;
Esteves, William Antonio M;
Nascimento, Bruno R;
Hung, Judy;
Levine, Robert;
Silva, Vicente Resende;
Castro, Marildes Luiza;
Chavez, Luz Marina Tacuri;
Silva, José
Luiz Padilha da;
Mello, Luana Aguiar;
Ruffo, Fernando Cunha;
Andrade, André
Barbosa;
Tan, Timothy;
Passaglia, Luiz Guilherme;
Freire, Claudia Maria Vilas;
Nunes, Maria Carmo P;
Post Graduation Program in Infectious Diseases and Tropical Medicine, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil;
Hospital das Clinicas, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil;
Hospital das Clinicas, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil;
Cardiac Ultrasound Lab, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA;
Cardiac Ultrasound Lab, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA;
Post Graduation Program in Infectious Diseases and Tropical Medicine, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil;
Hospital das Clinicas, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil;
Post Graduation Program in Infectious Diseases and Tropical Medicine, School of Medicine, Universidade Federal de Minas Ge;
(Open heart,
v.10,
2023,
pp.e002295-e002295)
-
25
-
Ecosystem heterogeneity determines the ecological resilience of the Amazon to climate change
-
Levine, Naomi M.;
Zhang, Ke;
Longo, Marcos;
Baccini, Alessandro;
Phillips, Oliver L.;
Lewis, Simon L.;
Alvarez-Dá
vila, Esteban;
Segalin de Andrade, Ana Cristina;
Brienen, Roel J. W.;
Erwin, Terry L.;
Feldpausch, Ted R.;
Monteagudo Mendoza, Abel Lorenzo;
Nuá
ñ
ez Vargas, Percy;
Prieto, Adriana;
Silva-Espejo, Javier Eduardo;
Malhi, Yadvinder;
Moorcroft, Paul R.;
Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138;
;
Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138;
;
Department of Earth and Planetary Sciences, Harvard University, Cambridge, MA 02138;
;
The Woods Hole Research Center, Falmouth, MA 02540-1644;
;
School of Geography, University of Leeds, Leeds LS2 9JT, United Kingdom;
;
School of Geography, University of Leeds, Leeds LS2 9JT, United Kingdom;
;
Jardá
ñ
í
n Botá
ñ
í
á
nico de Medellá
ñ
í
á
í
n, Grupo de Investigaciá
ñ
í
á
í
ó
n en Servicios Ecosistá
ñ
í
á
í
ó
é
micos y Cambio Climá
ñ
í
á
í
ó
é
á
tico, 14 Medellin, Colombia;
;
Instituto Nacional de Pesquisas da Amazá
ñ
í
á
í
ó
é
á
ô
nia, Manaus - AM, 69067;
(Proceedings of the National Academy of Sciences of the United States of America,
v.113,
2016,
pp.793-797)
-
26
-
Movement and Song Idiom Traditional to Enhance Early Mathematical Skills: Gelantram Audio-visual Learning Media
-
Hidayatulloh Taufik;
Yetti Elindra;
Hapidin;
;
(JPUD - Jurnal Pendidikan Usia Dini,
v.14,
2020,
pp.215-230)
-
27
-
Development of the 2023 <small>ACR/EULAR</small> Antiphospholipid Syndrome Classification Criteria, Phase III‐D Report: Multicriteria Decision Analysis
-
Barbhaiya, Medha;
Zuily, Stephane;
Amigo, Mary‐
Carmen;
Andrade, Danieli;
Avcin, Tadej;
Bertolaccini, Maria Laura;
Branch, D. Ware;
Costedoat‐
Chalumeau, Nathalie;
Crowther, Mark;
Ramires de Jesus, Guilherme;
Devreese, Katrien M. J.;
Frances, Camille;
Garcia, David;
Gó
mez‐
Puerta, Jose A.;
Guillemin, Francis;
Levine, Steven R.;
Levy, Roger A.;
Lockshin, Michael D.;
Ortel, Thomas L.;
Petri, Michelle;
Sanna, Giovanni;
Sciascia, Savino;
Seshan, Surya V.;
Tektonidou, Maria G.;
Wahl, Denis;
Willis, Rohan;
Yelnik, Cecile;
Hendry, Alison;
Naden, Ray;
Costenbader, Karen;
Erkan, Doruk;
Hospital for Special Surgery, Weill Cornell Medicine New York City New York;
CHRU‐
Nancy, Nancy University Hospital, INSERM UMR‐
S 1116, University of Lorraine F‐
54000 Nancy France;
ABC Medical Center Mexico City Mexico;
University of Sã
o Paulo Sao Paulo Brazil;
Children's Hospital, University Medical Center, University of Ljubljana Ljubljana Slovenia;
King's College London British Heart Foundation Centre of Excellence London United Kingdom;
University of Utah Health Salt Lake City;
APHP, Hopital Cochin, Université
de Paris, Centre de Recherche É
pidé
miologie et Biostatistiques de Sorbonne Paris Cité
F‐
75004 Paris France;
McMaster University Hamilton Ontario Canada;
Universidade do Estado do Rio de Janeiro Rio de Janeiro Brazil;
Ghent University Hospital, Ghent University Ghent Belgium;
Tenon Hospital Paris France;
University of Washington Seattle;
Hospital Clinic and IDIBAPS Barcelona Spain;
CHRU, INSERM, Univer;
(Arthritis care & research,
v.76,
2024,
pp.1617-1625)
-
28
-
Author Correction: Fundamental immune–oncogenicity trade-offs define driver mutation fitness
-
Hoyos, David;
Zappasodi, Roberta;
Schulze, Isabell;
Sethna, Zachary;
de Andrade, Kelvin Cé
sar;
Bajorin, Dean F.;
Bandlamudi, Chaitanya;
Callahan, Margaret K.;
Funt, Samuel A.;
Hadrup, Sine R.;
Holm, Jeppe S.;
Rosenberg, Jonathan E.;
Shah, Sohrab P.;
Vá
zquez-Garcí
a, Ignacio;
Weigelt, Britta;
Wu, Michelle;
Zamarin, Dmitriy;
Campitelli, Laura F.;
Osborne, Edward J.;
Klinger, Mark;
Robins, Harlan S.;
Khincha, Payal P.;
Savage, Sharon A.;
Balachandran, Vinod P.;
Wolchok, Jedd D.;
Hellmann, Matthew D.;
Merghoub, Taha;
Levine, Arnold J.;
Łuksza, Marta;
Greenbaum, Benjamin D.;
Computational Oncology, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY USA;
Swim Across America Laboratory and Ludwig Collaborative, Immunology Program, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY USA;
Swim Across America Laboratory and Ludwig Collaborative, Immunology Program, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY USA;
Computational Oncology, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY USA;
Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, National Institutes of Health, Rockville, MD USA;
Department of Medicine, Weill Cornell Medical College, New York, NY USA;
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA;
Department of Medicine, Weill Cornell Medical College, N;
(Nature,
v.606,
2022,
pp.E5-E5)
-
29
-
Fundamental immune–oncogenicity trade-offs define driver mutation fitness
-
Hoyos, David;
Zappasodi, Roberta;
Schulze, Isabell;
Sethna, Zachary;
de Andrade, Kelvin Cé
sar;
Bajorin, Dean F.;
Bandlamudi, Chaitanya;
Callahan, Margaret K.;
Funt, Samuel A.;
Hadrup, Sine R.;
Holm, Jeppe S.;
Rosenberg, Jonathan E.;
Shah, Sohrab P.;
Vá
zquez-Garcí
a, Ignacio;
Weigelt, Britta;
Wu, Michelle;
Zamarin, Dmitriy;
Campitelli, Laura F.;
Osborne, Edward J.;
Klinger, Mark;
Robins, Harlan S.;
Khincha, Payal P.;
Savage, Sharon A.;
Balachandran, Vinod P.;
Wolchok, Jedd D.;
Hellmann, Matthew D.;
Merghoub, Taha;
Levine, Arnold J.;
Łuksza, Marta;
Greenbaum, Benjamin D.;
Computational Oncology, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY USA;
Swim Across America Laboratory and Ludwig Collaborative, Immunology Program, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY USA;
Swim Across America Laboratory and Ludwig Collaborative, Immunology Program, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY USA;
Computational Oncology, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY USA;
Division of Cancer Epidemiology and Genetics, Clinical Genetics Branch, National Cancer Institute, National Institutes of Health, Rockville, MD USA;
Department of Medicine, Weill Cornell Medical College, New York, NY USA;
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA;
Department of Medicine, Weill Cornell Medical College, N;
(Nature,
v.606,
2022,
pp.172-179)
-
30
-
Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
-
Cohen, Hannah;
Werring, David J.;
Chandratheva, Arvind;
Mittal, Prabal;
Devreese, Katrien M.J.;
Isenberg, David A.;
Amoura, Zahir;
Andrade, Danieli;
Baccouche, Hela;
Baldwin, Neil;
Baysal, Mehmet;
Belmont, H. Michael;
Bertolaccini, M. Laura;
Billett, Henny;
Cervera, Ricard;
Cohen, Hannah;
Chandratheva, Arvind;
Cotelli, Maria Sofia;
Crowther, Mark;
Devreese, Katrien;
Dounaevskaia, Vera;
Doyle, Andrew J.;
Barros Duran, Leandro Francisco;
Engelbrecht, Sunelle;
Efthymiou, Maria;
Erkan, Doruk;
Gatt, Alex;
Gebhart, Johanna;
Harkness, Kirsty;
Hemelsoet, Dimitri;
Hoirisch-Clapauch, Silvia;
Inanc, Murat;
Isenberg, David;
Iturre, Maximiliano Villagra;
Kalladka, Dheeraj;
Kamphuisen, Pieter W.;
Kartsios, Charalampos;
Khamashta, Munther;
Kouides, Peter A.;
Levine, Steven R.;
Limper, Maarten;
Luchtman-Jones, Lori;
Maclean, Rhona;
Mitchell, Christopher;
Mittal, Prabal;
Moll, Rachel;
Molnar, Soledad;
Moyer, Genevieve Claire;
Muñ
oz Muñ
oz, C&;
;
(Journal of thrombosis and haemostasis : JTH,
v.21,
2023,
pp.2963-2976)